Nu Skin Enterprises Inc(NUS) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | RUT | P/E | - | EPS (ttm) | -4.47 | Insider Own | 2.95% | Shs Outstand | 48.7M | Perf Week | -5.63% |
| Market Cap | 0.23B | Forward P/E | 4.04 | EPS next Y | 41.46% | Insider Trans | -1.18% | Shs Float | 47.2M | Perf Month | 1.3% |
| Enterprise Value | 0.30B | PEG | - | EPS next Q | 0.21 | Inst Own | 75.19% | Short Float | 9.77% | Perf Quarter | -10.67% |
| Income | -0.22B | P/S | 0.17 | EPS this Y | -35.43% | Inst Trans | 1.92% | Short Ratio | 8.77 | Perf Half Y | -37.3% |
| Sales | 1.38B | P/B | 0.42 | EPS next 5Y | - | ROA | -16.87% | Short Interest | 4.62M | Perf YTD | -51.25% |
| Book/sh | 11.14 | P/C | 1.19 | EPS past 3/5Y | 15.37% -2.56% | ROE | -32.53% | 52W High | -59.81% ($11.67) | Perf Year | -57.44% |
| Cash/sh | 3.93 | P/FCF | 21.18 | Sales past 3/5Y | -12.61% -10.47% | ROIC | -27.51% | 52W Low | 5.51% ($4.45) | Perf 3Y | -75.69% |
| Dividend Est. | $0.24 (5.12%) | EV/EBITDA | 2.5 | EPS Y/Y TTM | -319.79% | Gross Margin | 69.19% | Volatility(W/M) | 4.1% 3.37% | Perf 5Y | -88.54% |
| Dividend TTM | 0.24 | EV/Sales | 0.22 | Sales Y/Y TTM | -15.44% | Oper. Margin | 5.11% | ATR (14) | 0.18 | Perf 10Y | -92.38% |
| Dividend Ex-Date | 2026/8/28 | Quick Ratio | 1.24 | EPS Q/Q | -1304.66% | Profit Margin | -15.73% | RSI (14) | 44.37 | Recom | 3 |
| Dividend Gr. 3/5Y | -46.19% -30.69% | Current Ratio | 1.98 | Sales Q/Q | -17.1% | SMA20 | -2.71% ($4.82) | Beta | 0.91 | Target Price | $12.77 |
| Payout | 7.54% | Debt/Eq | 0.49 | Earnings | 2026/11/5 | SMA50 | -1.65% ($4.77) | Rel Volume | 0.91 | Prev Close | $4.79 |
| Employees | 8600 | LT Debt/Eq | 0.45 | EPS/Sales Surpr. | - -7.27% | SMA200 | -27.96% ($6.51) | Avg Volume(3M) | 0.53M | Price | $4.69 |
| IPO | 1996/11/22 | Option/Short | Yes/Yes | Trades | 2062 | Volume | 477,144 | Change | -2.09% |
💄 Nu Skin Enterprises (NUS) is a US-based household products and personal care company that supplies beauty and wellness products to global markets through direct selling. The company operates a differentiated product line centered on its ageLOC brand, combining skincare devices with nutritional supplements.
Over the past 1 year, on the lower side
60% below its 1-year high.
Traded about as much as usual. That is 91% of its average volume.
Next earnings report: November 5
9 days to go.
NUS keeps an operating profit but posts a net loss
Of every $100 in sales, $5.11 is kept as operating profit.
Tap to view numbers
Growth is moderate
Earnings are expected to grow by -35.4% this year.
Tap to view numbers
Relative to sales, it looks cheap
Loss-making, so we compare on sales. For a company selling $100 a year, you would pay $17. Peers typically go for $149. Compared with its own 3-year average, it is 72% cheaper now.
Tap to view numbers
Results came in about as expected
Mixed beats and misses
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Hold.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -88.5%. The S&P 500 did +68% over the same period.
Tap to view numbers
Dividends are paid consistently
Pays 5.12% annually in dividends.
Tap to view numbers
Ownership looks stable
Institutions hold 75.2%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #20 of 30 in the industry
Based on market cap of $228M.
FAQ
What kind of company is NUS?
NUS belongs to the Consumer Defensive sector and operates in the Household & Personal Products industry.
What is the market cap of NUS?
The market cap of NUS is approximately $228M, ranking 3,916 within its sector.
Does NUS pay dividends?
NUS has a dividend yield of approximately 5.12%, with an annual dividend of $0.24.
What is the 52-week high and low for NUS?
NUS has recorded a 52-week high of $11.67 and a low of $4.45.